Simvastatin: increased risk of myopathy/rhabdomyolysis

Thumbnail
View/Open
View Statistics
Show Statistical Information
Altmetrics
Share
Citation
Unknown author (‎2012)‎. Simvastatin: increased risk of myopathy/rhabdomyolysis. WHO Drug Information 2012; 26(‎4)‎ : 382 https://iris.who.int/handle/10665/110339
Journal
WHO Drug Information 2012; 26(‎4)‎ : 382
Language
English
Collections
Metadata
Show full item record